Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: Frueh Klaus (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77777	Direct
Common Stock	144444	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.49	2027-10-05	Common Stock (42377)		Direct
Series A-2 Convertible Preferred Stock	$		Common Stock (218400)		Indirect

Footnotes

F1: The shares are held in the name of the Klaus and Renate Frueh Revocable Trust dated June 26, 2017.

F2: The option vests and becomes exercisable in 36 equal monthly installments following the grant date of October 5, 2017.

F3: Each share of Series A-2 Convertible Preferred Stock is convertible into one share of Common Stock and has no expiration date.